Target intelligence / Profile preview

COL4A2 antisense RNA 2 (COL4A2-AS2)

Target
COL4A2-AS2
Molecular classification
Long non-coding RNA (lncRNA), Other (Non-protein coding RNA)
01

Overview

COL4A2 antisense RNA 2 (COL4A2-AS2) is a long non-coding RNA transcribed antisense to the COL4A2 gene and is classified as a non-protein-coding RNA. It has been identified as differentially expressed in subcutaneous adipose tissue of women with obesity and shows dynamic expression during adipogenic differentiation of adipose-derived stem cells. Its expression appears to be modulated by key adipogenic transcription factors (C/EBPs, PPARγ), implicating it in regulatory networks controlling adipocyte differentiation, although the precise mechanisms remain undefined and literature is limited. Currently, there is no evidence that COL4A2-AS2 itself is a direct therapeutic target, nor are drugs known to interact with it. Its main biological significance appears to be regulatory within adipogenesis and potentially obesity pathology, but its broader disease relevance and mechanisms require more research.

Other names
COL4A2-AS2COL4A2 antisense 2COL4A2 antisense RNA 2 (non-protein coding)
02

Mechanism of action

Not applicable (no drugs known to target; the RNA acts at the transcriptional or post-transcriptional regulatory level)

03

Biological functions

Regulation of adipogenesis (differentiation of adipose-derived stem cells into adipocytes)Potential transcriptional regulation during adipogenesis via interaction with adipogenic transcription factors such as C/EBPs and PPARγ
04

Disease associations

Obesity (differentially expressed in subcutaneous adipose tissue in women with obesity and may play a role in obesity-related pathology)Other (No direct evidence for roles in cancer, cardiovascular, or other specific disorders currently)
05

Biomarkers

Potentially a biomarker for adipogenesis or obesity-related changes in adipose tissue

Beyond the preview

Go deeper on COL4A2 antisense RNA 2 (COL4A2-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COL4A2 antisense RNA 2 (COL4A2-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call